- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2005-005368-10.
Displaying page 1 of 1.
EudraCT Number: 2005-005368-10 | Sponsor Protocol Number: 1206.5 | Start Date*: 2006-07-04 | |||||||||||
Sponsor Name:Boehringer Ingelheim GmbH & Co. KG | |||||||||||||
Full Title: A 12 week double-blind, randomised, placebo-controlled, modified dose-escalation trial to investigate safety, efficacy, and pharmacokinetics of BIRT 2584XX tablets at doses of 100, 300 and 500 mg a... | |||||||||||||
Medical condition: Moderate to severe plaque-type psoriasis (defined as involving ≥ 10% body surface area, with minimum disease severity PASI ≥ 10 and with static PGA of at least moderate (score of at least 3)] | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) FI (Prematurely Ended) BE (Completed) ES (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.